ArticleMethodsX2026
Automated solvent-assisted flavor evaporation 2.0 (aSAFE 2.0).
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Before using gas chromatography to analyze volatiles in food, beverages, or other materials, it is necessary to carefully separate the volatile fraction from the nonvolatile compounds. Mild approaches that avoid elevated temperatures such as the solvent-assisted flavor evaporation are key to prevent compositional changes associated with compound degradation and artifact formation. This paper introduces a novel system for the automated execution of a solvent-assisted flavor evaporation that combines a newly designed glassware with a novel light-weight valve, a novel modernized controller, and an endpoint detection sensor. In summary, the major advantages of the novel aSAFE 2.0 system for the isolation of volatiles in the lab are:•Representativeness of the volatile isolates: no thermal compound degradation or artifact formation, high yields over a wide range of boiling points•Purity of the volatile isolates: reduced risk of unintended transfers of nonvolatiles•Convenience of handling: easy programming, autonomous execution, automatic shutdown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.